Clinical trial

Nitrite Effects on Cardiac Muscle in CABG

NCT04001283

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-01-21

PhasePHASE2

Study timeline

Study start (actual)2013-01-21Date precision: day

Registry last updated2019-06-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Coronary Artery Diseaseverified · MONDO: coronary artery disorder

Atherosclerosisverified · MONDO: atherosclerosis

Vascular Diseasesunresolved

Cardiac Diseaseverified · MONDO: heart disorder

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

Sodium NitriteDRUG · verified · RxNorm: sodium nitrite

0.9% Sodium-chlorideDRUG

Sponsors & collaborators

University of East Anglialead sponsor

Mapped research locations

CambridgeUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04001283 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.